SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001764013-21-000079
Filing Date
2021-08-09
Accepted
2021-08-09 07:09:11
Documents
53
Period of Report
2021-06-30

Document Format Files

Seq Description Document Type Size
1 10-Q imvt-20210630.htm   iXBRL 10-Q 1257488
2 EX-31.1 exhibit311-q1.htm EX-31.1 9601
3 EX-31.2 exhibit312-q1.htm EX-31.2 9520
4 EX-32.1 exhibit321-q1.htm EX-32.1 4491
5 EX-32.2 exhibit322-q1.htm EX-32.2 4480
  Complete submission text file 0001764013-21-000079.txt   4484784

Data Files

Seq Description Document Type Size
6 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT imvt-20210630.xsd EX-101.SCH 26432
7 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE DOCUMENT imvt-20210630_cal.xml EX-101.CAL 38164
8 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE DOCUMENT imvt-20210630_def.xml EX-101.DEF 187705
9 XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT imvt-20210630_lab.xml EX-101.LAB 390965
10 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT imvt-20210630_pre.xml EX-101.PRE 267900
11 EXTRACTED XBRL INSTANCE DOCUMENT imvt-20210630_htm.xml XML 474711
Mailing Address 320 WEST 37TH STREET NEW YORK NY 10018
Business Address 320 WEST 37TH STREET NEW YORK NY 10018 917-580-3099
Immunovant, Inc. (Filer) CIK: 0001764013 (see all company filings)

IRS No.: 832771572 | State of Incorp.: DE | Fiscal Year End: 0331
Type: 10-Q | Act: 34 | File No.: 001-38906 | Film No.: 211154609
SIC: 2836 Biological Products, (No Diagnostic Substances)
Office of Life Sciences